Thermo Fisher Scientific, LIMS & Laboratory Software
9 services found

Thermo Fisher Scientific, LIMS & Laboratory Software services

Cryo-EM Access Services

Our partner service centers that include contract research organizations (CRO) offer three unique levels of cryo-EM service ideal for scientists who are curious about cryo-EM but want proof that the technology can provide high-value structural insights for their drug discovery projects. In this controlled environment, you can discover the value and true potential of cryo-EM for structure-based drug design. Learn the technology from cryo-EM experts and give yourself an unprecedented advantage with never-before-seen structural insights that make for more effective drugs. These service centers have partnered with Thermo Fisher Scientific to offer you the services you need to succeed.

Managed Equipment Solutions (MES)

A Managed Equipment Solution (MES) is a value-added procurement model, providing customers continuous access to our latest advancements in technology innovations. As a subscription-based agreement, MES offers a comprehensive solution for the smooth operation of your analytical technologies including instrumentation, extended service, software, consumables and other related operating costs such as training, qualification and applications support. An all-inclusive solution, MES can actually reduce total cost of ownership, while preserving capital budgets. At the same time, it minimizes the risk of obsolescence by enabling you to upgrade technology on a three to five-year basis and maintain a predictable payment plan for everything needed to run your workflow.

Thermo Fisher Scientific - Amplitude Solution

The Thermo Fisher Scientific Amplitude Solution is a new, high throughput, highly automated molecular testing solution that can analyze up to 8,000 SARS-CoV-2 specimens in 24 hours. The Amplitude Solution allows laboratories to quickly scale SARS-CoV-2 testing to the volumes needed to meet demand. This high throughput workflow solution maximizes laboratory operational efficiencies by automating sample processing and minimizing staffing requirements.



Bioprocessing Solutions

With a proven portfolio of solutions that span discovery through large-scale commercial production, we bring process intensification across your upstream and downstream workflows, without compromising on quality. And to stay ahead of future bioprocessing needs, we are focused on working with customers and utilizing our unique capabilities, like open architecture engineering and customization, to provide the right solutions to achieve optimal bioprocessing outcomes. That’s our commitment to you and it’s what we call Bioprocessing by Design.

In-Air Pathogen Surveillance Solution

Next-level confidence, safety, and reliability: Leaders of organizations large and small, from the national to the local level, are confronted by a vast array of new and urgent questions.

Validated Haloacetic Acids Analysis (HAAs) IC/MS Workflow

Drinking water disinfection by-products by IC-MS/MS: Disinfection is important in ensuring the supply of pathogen-free drinking water. However, excessive consumption of disinfection by-products (DBPs) like haloacetic acids (HAAs), bromate, and dalapon can result in health issues. With increasing regulatory focus on DBPs, drinking water facilities around the world need hands-off, high-throughput analyses of these contaminants.

Ion AmpliSeq SARS-CoV-2 - Insight Research Assay

Unlock low-titer samples with superior sensitivity and robust performance. The Ion AmpliSeq SARS-CoV-2 Insight Research Assay leverages a unique targeted sequencing approach that yields improved coverage and uniformity from samples previously unobtainable by NGS. Incorporation of intelligent panel design provides an increased resilience to new mutations introduced within the viral genome. Integrated analysis tools enable automated consensus sequence generation, mutation annotation, and lineage assignment.

Quick to Clinic - Large Molecule Biologics Development Services

Quick to Clinic is an integrated early development offering designed for biotech companies looking for a dependable solution to scale up recombinant antibodies from discovery to first-in-human (FIH) trials. With Quick to Clinic, you balance early development timelines, risks, and future scale-up and commercialization needs. Speed up your early development to as little as 13 months from the start of transfection to IND with best-in-class technologies, allowing you to file faster and get to patients sooner.

Rapid DNA Solutions

Every minute that a crime remains unsolved is time for someone else to become a victim. Imagine what can happen when DNA testing takes only minutes, instead of days, weeks, or even months.